Inmed Pharmaceuticals Inc.
13F holders, Q1 2024 (March 31)18holders
2famous investors
$0.36avg. 13F price*
At the end of Q1 2024, 18 institutions reported holding Inmed Pharmaceuticals Inc. in their 13F filings. The largest holders were Sabby Management, LLC ($132K), Armistice Capital, LLC ($97K) and Renaissance Technologies ($10K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Inmed Pharmaceuticals Inc.
- CUSIP
- 457637601
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $117 |
| Exits | 2 | $68 |
Ownership 18 holders
| Sabby Management, LLC | 0.95% | Reduce -29.3% | 361,728 | $132K |
| Armistice Capital, LLC | 0.00% | Add +29.6% | 266,968 | $97K |
| Renaissance Technologies | 0.00% | Reduce -27.3% | 28,300 | $10K |
| Two Sigma Securities, LLC | 0.00% | Add +19.6% | 15,423 | $6K |
| Citadel Advisors | 0.00% | Reduce -62.6% | 12,725 | $4K |
| Bfsg, LLC | 0.00% | New | 200 | $73 |
| Qube Research & Technologies Ltd | 0.00% | No change | 200 | $70 |
| Bank of America Corp. | 0.00% | No change | 100 | $36 |
| AdvisorNet Financial, Inc | 0.00% | New | 80 | $29 |
| UBS Group AG | 0.00% | New | 41 | $15 |
| Osaic Holdings, Inc. | 0.00% | No change | 41 | $13 |
| AllSquare Wealth Management LLC | 0.00% | No change | 21 | $8 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 19 | $7 |
| National Bank of Canada | 0.00% | No change | 12 | $3 |
| Global Retirement Partners, LLC | 0.00% | No change | 6 | $2 |
| Toronto Dominion Bank | 0.00% | No change | 2 | $1 |
| Royal Bank of Canada | 0.00% | Add +127.3% | 25 | $0 |
| Gables Capital Management Inc. | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is INMED PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Inmed Pharmaceuticals Inc. the manager owns.